GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Bragg Financial Advisors Inc

Bragg Financial Advisors Inc lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,570 shares of the company’s stock after selling 265 shares during the quarter. Bragg Financial Advisors Inc’s holdings in GE HealthCare Technologies were worth $201,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Cathy Pareto & Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at approximately $670,000. Principal Financial Group Inc. increased its holdings in shares of GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after purchasing an additional 19,010 shares during the period. Everence Capital Management Inc. raised its stake in shares of GE HealthCare Technologies by 118.2% during the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after purchasing an additional 10,220 shares in the last quarter. Apollon Wealth Management LLC lifted its holdings in GE HealthCare Technologies by 46.5% in the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock worth $1,025,000 after purchasing an additional 4,160 shares during the period. Finally, Sanibel Captiva Trust Company Inc. increased its stake in GE HealthCare Technologies by 139.9% during the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 7,484 shares of the company’s stock valued at $585,000 after buying an additional 4,364 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $97.73.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $64.39 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a market cap of $29.45 billion, a PE ratio of 14.87, a PEG ratio of 3.19 and a beta of 1.14. The stock’s 50-day moving average price is $81.29 and its two-hundred day moving average price is $83.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.22%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.